ES2040210T3 - Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados. - Google Patents

Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados.

Info

Publication number
ES2040210T3
ES2040210T3 ES198686308172T ES86308172T ES2040210T3 ES 2040210 T3 ES2040210 T3 ES 2040210T3 ES 198686308172 T ES198686308172 T ES 198686308172T ES 86308172 T ES86308172 T ES 86308172T ES 2040210 T3 ES2040210 T3 ES 2040210T3
Authority
ES
Spain
Prior art keywords
diana
polypeptide
directing
sites
activated lymphocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686308172T
Other languages
English (en)
Inventor
Thorfinn Ege
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed AS filed Critical Nycomed AS
Application granted granted Critical
Publication of ES2040210T3 publication Critical patent/ES2040210T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

OBJETIVIZACION DE POLIPEPTIDOS PARA USO EN LA OBJETIVIZACION E IDENTIFICACION DE LINFOCITOS T - ACTIVADOS EN EL CUERPO HUMANO O DE ANIMALES, DICHOS POLIPEPTIDOS OBJETIVABLES SIENDO CAPACES DE ENLAZAR ESPECIFICAMENTE A LOS RECEPTORES DE INTERLEUQUINA - 2 DE LINFOCITOS T ACTIVADOS O A MOLECULAS ASOCIADAS CON DICHOS RECEPTORES Y PORTANDO UNO O MAS AGENTES DE IMAGEN COMPATIBLES FISIOLOGICAMENTE. DICHOS POLIPEPTIDOS OBJETIVABLES PUEDEN SER USADOS TAL COMO EN LA LOCALIZACION DE TUMORES, ABCESOS Y OTRAS CONDICIONES INFLAMATORIAS, Y EN LA MONITORIZACION DE TRASPLANTES DE TEJIDO PARA DETECTAR POSIBLES RECHAZOS.
ES198686308172T 1985-10-22 1986-10-21 Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados. Expired - Lifetime ES2040210T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525974A GB8525974D0 (en) 1985-10-22 1985-10-22 Chemical substance

Publications (1)

Publication Number Publication Date
ES2040210T3 true ES2040210T3 (es) 1993-10-16

Family

ID=10587035

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686308172T Expired - Lifetime ES2040210T3 (es) 1985-10-22 1986-10-21 Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados.

Country Status (8)

Country Link
US (1) US4832940A (es)
EP (1) EP0236619B1 (es)
JP (1) JP2727074B2 (es)
AT (1) ATE71306T1 (es)
DE (1) DE3683368D1 (es)
ES (1) ES2040210T3 (es)
GB (1) GB8525974D0 (es)
NO (1) NO174326C (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330896A (en) * 1983-02-24 1994-07-19 Billing Ronald J Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells
AU6621586A (en) * 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US6461825B1 (en) * 1987-09-30 2002-10-08 Sanofi (Societe Anonyme) Immunometric assay kit and method applicable to whole cells
EP0381742B1 (en) * 1988-08-04 1996-06-19 Advanced Magnetics Incorporated Receptor mediated endocytosis type mri contrast agents
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
EP0485664A1 (en) * 1990-11-13 1992-05-20 Mallinckrodt Diagnostica (Holland) B.V. Method of preparing a diagnostic agent for detecting inflammations
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5605671A (en) * 1992-10-05 1997-02-25 The Regents Of The University Of Michigan Radiolabeled neutrophil activating peptides for imaging
US5346686A (en) * 1992-10-05 1994-09-13 Mallinckrodt Medical, Inc. Labelled interleukin-8 and medical uses thereof
AU5537994A (en) * 1992-10-22 1994-05-09 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
US6008319A (en) * 1996-12-23 1999-12-28 University Of Southern California Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
DK1286704T3 (da) 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
ITRM20030159A1 (it) * 2003-04-07 2004-10-08 Uni Degli Studi Di Roma L A Sapienza Citochine radiomarcate e loro usi come traccianti scintigrafici per la visualizzazione delle infiammazioni croniche linfocito-mediate.
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
JP2009539501A (ja) * 2006-06-06 2009-11-19 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー ヨウ化ポリマー
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
IT201900011013A1 (it) 2019-07-05 2021-01-05 Sapienza Univ Di Roma Composto e composizione radiofarmaceutici per l’imaging con tecnica di Tomografia a Emissione di Positroni (PET) di cellule positive al recettore dell’interleuchina-2, processo per la loro preparazione, relativo kit e loro usi.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
EP0111344A2 (en) * 1982-12-13 1984-06-20 Sloan-Kettering Institute For Cancer Research Anti-interleukin-2 monoclonal antibodies
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
DE3484198D1 (de) * 1983-07-29 1991-04-04 Milton David Goldenberg Verfahren zur erhoehung der zielspezifizitaet in antikoerperbestimmungen und zur raeumung von nichtzielspezifischen diagnostischen und therapeutischen faktoren.
US4634586A (en) * 1984-05-21 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Reagent and method for radioimaging leukocytes
US4578335A (en) * 1984-05-21 1986-03-25 Immunex Corporation Interleukin 2 receptor
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes

Also Published As

Publication number Publication date
ATE71306T1 (de) 1992-01-15
US4832940A (en) 1989-05-23
DE3683368D1 (de) 1992-02-20
EP0236619B1 (en) 1992-01-08
EP0236619A1 (en) 1987-09-16
GB8525974D0 (en) 1985-11-27
NO864203L (no) 1987-04-23
NO864203D0 (no) 1986-10-21
NO174326B (no) 1994-01-10
JP2727074B2 (ja) 1998-03-11
JPS62187498A (ja) 1987-08-15
NO174326C (no) 1994-04-20

Similar Documents

Publication Publication Date Title
ES2040210T3 (es) Polipeptido para uso en dirigirlo a sitios diana e identificar linfocitos t activados.
DE69014474T2 (de) Antikörper gegen TNF-Bindungsprotein I und deren F(ab)-Fragmente.
BR8707612A (pt) Dispositivo para uso no manuseio de fluidos corporais
DE3689784T2 (de) Das kationische Merichinon eines Benzidins enthaltende ionische Komponenten, diese enthaltende Testkombinationen und deren Gebrauch bei Untersuchungen.
IT1272598B (it) Dispositivo per il prelievo e trasporto di campioni in vitro principalmente per uso diagnostico
EP0188256A3 (en) Metal radionuclide labeled proteins for diagnosis and therapy
ES8602121A1 (es) Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana
SE8000470L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
MX9201886A (es) Analisis de diagnostico para mutaciones geneticas asociadas con deficiencia de adhesion de leucocitos en bovinos.
DE3671970D1 (de) Probekoerper fuer ultraschallpruefung.
IL60948A (en) Flavin adenine dinucleotide-labeled protein or polypeptide conjugates and their use in immunoassay methods
BR9003001A (pt) Prendedor e juncao de esteira
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
DE3887053D1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
DE69003958T2 (de) Laser mit Halterungsvorrichtung des aktiven Materials und Halterungsvorrichtung für den Laseraufbau.
DE3686766D1 (de) Monoklonaler antikoerper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
ES2046187T3 (es) Anticuerpos para uso en la determinacion de la glucoalbumina humana.
DE69027542T2 (de) Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
IT1180166B (it) Composizione ad attivita' farmaceutica perfezionata e sua utilizzazione per usi veterinari
ES2183376T3 (es) Uso de lbp para el tratamiento de la septicemia.
中沢修 et al. CHARACTERIZATION OF TC II LIKE NOVEL COBALAMIN BINDING PROTEIN IN A PATIENT WITH HEPATOMA

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 236619

Country of ref document: ES